| Title |
The nocebo effect challenges the non-medical infliximab switch in practice
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, January 2018
|
| DOI | 10.1007/s00228-018-2418-4 |
| Pubmed ID | |
| Authors |
N. W. Boone, L. Liu, M. J. Romberg-Camps, L. Duijsens, C. Houwen, P. H. M. van der Kuy, R. Janknegt, R. Peeters, R. B. M. Landewé, B. Winkens, A. A. van Bodegraven |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Canada | 1 | 33% |
| Austria | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 145 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 145 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 13% |
| Researcher | 16 | 11% |
| Student > Ph. D. Student | 15 | 10% |
| Other | 13 | 9% |
| Student > Bachelor | 12 | 8% |
| Other | 25 | 17% |
| Unknown | 45 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 12% |
| Nursing and Health Professions | 7 | 5% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Psychology | 3 | 2% |
| Other | 17 | 12% |
| Unknown | 52 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2019.
All research outputs
#7,629,858
of 26,017,215 outputs
Outputs from European Journal of Clinical Pharmacology
#867
of 2,829 outputs
Outputs of similar age
#143,812
of 456,413 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#6
of 23 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,829 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,413 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.